EP Wealth Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,028
| Closed | -$194K | – | 1205 |
|
|
2024
Q2 | $194K | Buy |
+15,028
| New | +$194K | ﹤0.01% | 763 |
|
|
2022
Q3 | – | Sell |
-21,220
| Closed | -$298K | – | 611 |
|
|
2022
Q2 | $298K | Buy |
21,220
+7,528
| +55% | +$106K | 0.01% | 483 |
|
|
2022
Q1 | $196K | Buy |
+13,692
| New | +$196K | ﹤0.01% | 579 |
|
|
2021
Q4 | – | Sell |
-12,294
| Closed | -$201K | – | 567 |
|
|
2021
Q3 | $201K | Buy |
+12,294
| New | +$201K | 0.01% | 513 |
|
|
2020
Q1 | – | Sell |
-10,443
| Closed | -$206K | – | 433 |
|
|
2019
Q4 | $206K | Buy |
+10,443
| New | +$206K | 0.01% | 391 |
|
|
2019
Q3 | – | Sell |
-10,546
| Closed | -$187K | – | 369 |
|
|
2019
Q2 | $187K | Buy |
+10,546
| New | +$187K | 0.01% | 300 |
|